Correlation of androgen receptor with ultrasound, clinicopathological features and clinical outcomes in breast cancer

被引：0
作者：
Xudong Zhang
Hao Cui
Nana Hu
Peng Han
Wei Fan
Panting Wang
Xiaoxuan Zuo
Dantong Zhao
He Huang
Shuo Li
Hanqing Kong
Fuhui Peng
Jiawei Tian
Lei Zhang
机构：
[1] The Second Affiliated Hospital of Harbin Medical University,Department of Ultrasound Medicine
[2] The Second Affiliated Hospital of Harbin Medical University,Department of Clinical Medicine
来源：
Insights into Imaging | / 14卷
关键词：
Breast cancer; Androgen receptor; Ultrasound; Nomogram; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In terms of clinicopathology, the probability of AR expression in different subtypes of breast cancer was various, and the positive expression of AR was associated with lower histological grade and lower Ki-67 level.In terms of ultrasound, the positive expression of AR was associated with unsmooth margin, posterior acoustic shadowing and stiffer on strain elastography, and AR + and AR– tumors performed differently when analyzed separately according to different molecular subtypes.The positive expression of AR could be a sign of a better prognosis in breast cancer.
引用
收藏
相关论文
共 161 条
  • [1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
  • [2] Ferlay J(2011)Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011 Ann Oncol 22 1736-1747
  • [3] Siegel RL(2015)Triple-negative breast cancer in African-American women: disparities versus biology Nat Rev Cancer 15 248-254
  • [4] Goldhirsch A(2011)Expression of androgen receptor in breast cancer and its significance as a prognostic factor Ann Oncol 22 1288-1294
  • [5] Wood WC(1975)Epithelial cancer and monoclonal immunoglobulins Sem Hop 51 817-821
  • [6] Coates AS(2017)Androgen receptor expression and Bicalutamide antagonize androgen receptor inhibit beta-catenin transcription complex in estrogen receptor-negative breast cancer Cell Physiol Biochem 43 2212-2225
  • [7] Dietze EC(2017)The androgen receptor: is it a promising target? Ann Surg Oncol 24 2876-2880
  • [8] Sistrunk C(2018)Research on the correlation between ultrasonographic features of breast cancer and expressions of ER, CD34 and p53 J BUON 23 372-377
  • [9] Miranda-Carboni G(2014)Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis Cancer Epidemiol Biomarkers Prev 23 1464-1483
  • [10] O'Regan R(2019)Interpretation of breast cancer screening guideline for Chinese women Cancer Biol Med 16 825-835
12345678910